Treatment of high-risk pediatric brain tumors with a CD133-targeted adenovirus in combination with temozolomide
|
University of Texas M.D. Anderson Cancer Center / Marta Alonso, PhD |
Young Investigator Grants |
2008 |
Texas |
Screening for New Rhabdomyosaroma Pathogenesis Genes in a Drosophila Model |
University of Texas Southwestern Medical Center / Kathleen Galindo |
Young Investigator Grants |
2012 |
Texas |
Synthetic Gene Expression Regulatory Switches (SynGERS) for Improved CAR T Cell Function in Pediatric Solid Tumors |
Baylor College of Medicine / Leidy Diana Caraballo Galva, PhD |
Young Investigator Grants |
2023 |
Texas |
In Situ CD19.CAR-T Generation Using TRIDENT System for Pediatric B Cell Malignancies |
Baylor College of Medicine / Masataka Suzuki, PhD |
Innovation Grants |
2023 |
Texas |
Interrogating the Enhancer Landscapes of Ependymoma to Inform Novel Therapies |
Baylor College of Medicine / Stephen Mack, PhD |
Young Investigator Grants |
2016 |
Texas |
Targeting PLK1 as a Common Mechanism in Ph-like ALL |
University of Texas M.D. Anderson Cancer Center / Joya Chandra, PhD |
Reach Grants |
2016 |
Texas |
Building a Texas-based center for neuroblastoma clinical research.
|
Baylor College of Medicine / Heidi Russell, MD |
Phase I/II Infrastructure Grants |
2006 |
Texas |
Combining Oncolytic Vaccinia Virus with GD2.CAR-modified Vaccinia Virus-specific T-cells for the Treatment of Relapsed Neuroblastoma and Sarcoma |
Baylor College of Medicine / Cliona Rooney, PhD |
Reach Grants |
2013 |
Texas |
Synthetic gene expression regulator switches (SynGERS) expressed in CAR T cells to cure children with solid tumors |
Baylor College of Medicine / Andras Heczey, MD |
R Accelerated Award Grants |
2023 |
Texas |
Mediators of Metastasis in Alveolar Rhabdomyosarcoma.
|
University of Texas Health Science Center at San Antonio / Koichi Nishijo, MD, PhD |
Young Investigator Grants |
2006 |
Texas |